Consumer Staples, Healthcare Jun 18, 2021 09:58 AM (GMT+8) · EqualOcean
The company announced in the Hong Kong stock exchange that the SHP2 inhibitor jab-3312 has been administered to the first patient in the clinical trial of PD-1 antibody pemuzumab and MEK inhibitor bimetinib respectively. Garth will receive a $20 million milestone payment from partner aberway.